NCT04989283 2023-09-26Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Withdrawn